Mankind Pharma Q4: Profit drops 10%, revenue up 27% on domestic growth

Quick Summary:

This compares to ₹589 crore and 24.3 per cent, respectively, in the same period last financial year.

The export business witnessed a growth of 100 per cent in the March quarter.

Mankind’s consumer healthcare segment also reported a revenue growth of 14 per cent in Q4.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Business 2025 Private Copyrights Standard

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-05-21 @ 20:09:21 (1 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 7 words

Reading Time: 1 minutes read

Sentences: 20 lines

Sentence Length: 1 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 28891045

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 279 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 7 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions